Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Mycobacterium Tuberculosis (M. tb)
79%
COVID-19
39%
Active Tuberculosis
24%
Multidrug-resistant Tuberculosis (MDR-TB)
20%
Migrants
19%
Whole Genome Sequencing
17%
SARS-CoV-2 Variants
17%
TB Incidence
17%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
16%
United Kingdom
16%
Contact Tracing
14%
Mycobacterial Interspersed Repetitive Units
14%
Variable number Tandem Repeat
14%
Alpha Variant
14%
Latent Tuberculosis Infection
12%
Low Incidence
12%
Drug Susceptibility Testing
11%
Latent Tuberculosis
11%
Risk Factors
11%
Tuberculosis Risk
10%
Transmissibility
10%
Epidemiological Study
10%
Public Health Preparedness
10%
Population-based Cohort Study
9%
Delta Variant
9%
Surnames
9%
Prospective Observational Cohort Study
9%
Sequence Data
8%
Variants of Concern
8%
World Health Organization
8%
Reinfection
8%
Tuberculosis Diagnosis
7%
Minimum Inhibitory Concentration
7%
Hospitalization
7%
Europe
7%
Social Risk
7%
Incidence Rate
7%
Interferon-gamma Release Assay
6%
Strain Typing
6%
Tuberculosis Treatment
6%
Treatment Efficacy
6%
Lessons Learned
6%
Wales
6%
Tuberculosis Surveillance
6%
Retrospective Cohort Analysis
6%
Prospective Cohort Study
6%
Genetic Resistance
6%
Public Health Management
5%
Primary Care
5%
Infectious Diseases
5%
Low-incidence Country
5%
Asylum Seekers
5%
Epidemiology
5%
Surveillance System
5%
National Institutes of Health
5%
Molecular Epidemiology
5%
Hospital Admission
5%
Virus
5%
Scotland
5%
Adjusted Odds Ratio
5%
Single nucleotide Polymorphism
5%
Screening Program
5%
Medicine and Dentistry
Tuberculosis
100%
Cohort Analysis
30%
COVID-19
24%
Public Health
24%
Multidrug Resistant Tuberculosis
23%
Latent Tuberculosis
21%
Diseases
19%
Whole Genome Sequencing
19%
Contact Examination
18%
Genetics
16%
Mycobacterium Tuberculosis
15%
Severe Acute Respiratory Syndrome Coronavirus 2
14%
Systematic Review
14%
Tandem Repeat
9%
Odds Ratio
7%
Infection
7%
Prevalence
7%
Directly Observed Therapy
7%
Interferon Gamma Release Assay
7%
Tuberculosis Treatment
7%
Treatment Outcome
7%
Observational Study
6%
Ethambutol
6%
Drug Use
6%
Cohort Effect
5%
Adverse Event
5%
Drug Resistance
5%
Health Care Personnel
5%
Prospective Cohort Study
5%
Prophylaxis
5%
Health Care
5%
Release Assay
5%
Interferon
5%